Search - tctmd.com

Displaying 1 - 20 of 41

Sort: Relevancy | Date

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

News Daily News

Half of Patients Stop Semaglutide for Weight Loss by 1 Year

Todd Neale

September 18, 2025

News Opinion CV Team Dispatch

July 2025 Dispatch for the CV Team

L.A. McKeown

July 24, 2025

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

Michael O'Riordan

May 14, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2025

Shelley Wood

January 31, 2025

Podcast Heart Sounds

Top Cardiology News for January 2025

January 29, 2025

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

News Daily News

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

Todd Neale

August 15, 2024

News Daily News

Improved Lipids With Gastric Bypass Linked to Surgery Itself, Not Weight Loss

Michael O'Riordan

July 23, 2024

News Daily News

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

Michael O'Riordan

June 25, 2024

News Daily News

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Michael O'Riordan

June 21, 2024

News Daily News

Don’t Worry About Muscle Loss With GLP-1 Inhibitors, Viewpoint Asserts

Yael L. Maxwell

June 10, 2024

News Daily News

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

Michael O'Riordan

February 07, 2024

News Conference News AHA 2023

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

Todd Neale

November 11, 2023

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

Shelley Wood

August 25, 2023

News Daily News

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Michael O'Riordan

July 12, 2023

News Conference News ADA 2023

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Shelley Wood

June 29, 2023

News Daily News

Obesity and CVD: New Review Highlights Where Tools and Meds Fall Short

Shelley Wood

January 31, 2023

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

L.A. McKeown

June 09, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

Advertisement

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Half of Patients Stop Semaglutide for Weight Loss by 1 Year

July 2025 Dispatch for the CV Team

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

TCTMD’s Top 10 Most Popular Stories for January 2025

Top Cardiology News for January 2025

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

Improved Lipids With Gastric Bypass Linked to Surgery Itself, Not Weight Loss

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Don’t Worry About Muscle Loss With GLP-1 Inhibitors, Viewpoint Asserts

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Obesity and CVD: New Review Highlights Where Tools and Meds Fall Short

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content